C. David James
North Western University
H-index: 103
Asia-Bangladesh
Top articles of C. David James
ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM
Neuro-Oncology
2024/3/20
Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas
Journal of Clinical Investigation
2024/2/15
The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions
2024/1/1
Immune Spatial Differences Between Short and Long-term Surviving Glioblastoma Patients
The Journal of Immunology
2023/5/1
Abstract LB335: Establishment of the effective dose of the STAT3 inhibitor WP1066 used in combination with STING activation for reprograming the preclinical glioma microenvironment
Cancer Research
2023/4/14
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
Neuro-oncology
2023/3/1
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
The Journal of clinical investigation
2023/12/15
Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma
Nature Immunology
2023/10
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas
Cancers
2023/6/30
IMMU-10. PILOCYTIC ASTROCYTOMAS SHOW EVIDENCE OF INTRINSIC IMMUNE SURVEILLANCE AND ACTIVATION WITHIN THE TUMOR MICROENVIRONMENT
Neuro-Oncology
2023/6/1
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production
Science Advances
2023/5/17
Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
Oncoimmunology
2022/12/31
Identification and characterization of a novel indoleamine 2, 3-dioxygenase 1 protein degrader for glioblastoma
Journal of Medicinal Chemistry
2022/11/21
Modeling therapy-driven evolution of glioblastoma with patient-derived xenografts
Cancers
2022/11/9
CDK 4/6 Inhibitors are Potent Radiosensitizers in Retinoblastoma Protein Positive Meningiomas
International Journal of Radiation Oncology, Biology, Physics
2022/11/1
SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
Cancer research communications
2022/9/13
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models
Clinical Cancer Research
2022/9/1
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era
2022/6/16
DNMT targeting enhances vulnerability of glioblastoma cells to MNK inhibition
Cancer Research
2022/6/15
The central nervous system immune cell interactome is a function of cancer lineage, tumor microenvironment and STAT3 expression
Cancer Research
2022/6/15